Experts from the Chest Diseases Group of the Chinese Society of Pathology Visit Maxin Company for Exchange and Communication

Posted by

6 2 月, 2026

On 6 2 月, 2026

Introduction:

On June 18th, Maxin Biotech was filled with distinguished guests and warm hospitality. Experts and professors from the Chest Diseases Group of the Chinese Society of Pathology, hailing from across the nation, visited our company for an exchange and discussion. Everyone gathered joyfully to share camaraderie, discuss the development of pathology, and exchange insights on topics such as innovations in pathological diagnostic technology, as well as Maxin’s development and future plans.

Welcoming Distinguished Guests

Chairman Wang Xiaoya first extended a sincere welcome to the pathology colleagues. Accompanied by our staff, the expert delegation visited our company’s exhibition hall, quality control laboratory, GMP cleanroom workshop, and other facilities. During the tour, our staff provided a brief introduction to the park’s overview andthe company’s development history, with a special focus on Maxin’s self-developed monoclonal antibodies and automated pathology products. The experts highly commended Maxin’s robust independent R&D capabilities and its modern, professional development.

Figure 1: Visiting Maxin’s exhibition hall to learn about the company’s development achievements

Figure 2: Reviewing experimental records and exploring the antibody quality inspection process

Figure 3: Discussing antibody R&D and production processes, praising independent innovation

Figure 4: Dialogue on cutting-edge technology, discussing the development of pathology together

Deep Friendship

Maxin’s development is inseparable from the support of our pathology colleagues. We will foster more industry exchanges to build a bridge of communication with pathology professionals, grasp the core needs of pathology workers, enhance mutual understanding, and use this as an opportunity to establish long-term, stable, and new customer-friendly collaborative relationships, injecting more driving force into the healthy development of China’s pathology industry!

The experts and professors expressed that they gained many insights from this visit. They were deeply impressed by Maxin’s stringent product quality inspection processes and professional R&D and production techniques. They highly agreed with and affirmed Maxin’s commitment to independent innovation and development, believing that such activities positively promote exchanges and collaboration between pathology professionals and enterprises, the practical application of technology, and eventhe development of the pathology discipline.

Solid Progress and Striving Forward

Building solid foundations and striving for development, riding the waves to compose new chapters. On the path of pathology advancement, Maxin looks forward to walking side by side with our pathology colleagues.

As a domestic national enterprise, we will actively promote the localization process of in vitro diagnostic reagents and instruments through various scientific research innovations, and provide all pathology colleagues with higher quality, more efficient, comprehensive, and reliable pathological diagnostic products and services,striving to build Maxin into a first-class innovative enterprise in the in vitro diagnostics industry, strongly supporting and promoting the construction and development of the pathology discipline, and contributing to building a bright future for Chinese pathology.

发表回复 取消回复

发表回复取消回复